Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Signs Up Quebec Distributor for H1N1 Test

NEW YORK (GenomeWeb News) – Warnex has signed up Biron Laboratoire medical, a diagnostic and medical services provider in Quebec, to distribute its test for influenza A H1N1, Warnex said yesterday.

Warnex said Biron, which operates more than 100 sites throughout Quebec, will promote and distribute the test and will specifically target industrial companies as customers.

The Warnex test uses RT-PCR to detect the A H1N1 strain in as little as eight hours, the company said.

"With the possibility of a significant incidence rate of the pandemic A H1N1 flu virus this fall, companies are increasingly concerned with the effect this might have on their workforce," Warnex CEO and President Mark Busgang said in a statement.

Busgang also said that the diagnostic test will enable employees to receive diagnosis earlier, "allowing company decision makers to rapidly take appropriate action to limit the spread of infection to the rest of the workforce."

Terms of the agreement were not disclosed.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.